FF-10101 is a FMS-like tyrosine kinase 3 (FLT3; CD135; STK1; FLK2) inhibitor, with potential antineoplastic activity.Upon administration of FLT3 inhibitor FF-10101 succinate (FF-10101-01), FF-10101 irreversibly binds to and inhibits the activity of FLT3. This inhibits the proliferation of FLT3-expressing cancer cells. FLT3, a class III receptor tyrosine kinase (RTK), is overexpressed or mutated in most B-lineage neoplasms and in acute myeloid leukemias. Check for active clinical trials using this agent. (NCI Thesaurus)
Sun-shine Chemical has completed the synthesis of FF-10101. and we may provide the product to clients with high quality and competitive price for your research.
For research use only. We do not sell to patients.